Table 2.

Cox proportional hazards models for time to islet autoimmunity and celiac autoimmunity in cotwins

CovariateHazard Ratio (95% Confidence Interval)P value
Time to IA in Dizygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.88 (0.78-1.00)0.047
 Proband’s sex0.37 (0.08-1.76)0.210
 DR3 present in proband0.95 (0.20-4.42)0.945
 DR4 present in proband0.79 (0.15-4.05)0.773
Time to IA in Monozygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.91 (0.84-0.98)0.012
 Proband’s sex0.97 (0.29-3.28)0.962
0.81 (0.26-2.51)0.716
 DR4 present in proband1.05 (0.32-3.47)0.938
Time to CDA in Dizygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.85 (0.66-1.08)0.187
 Proband’s sex0.21 (0.02-1.91)0.164
 DR3 present in proband0.43 (0.09-1.93)0.268
 DR4 present in proband0.47 (0.05-4.12)0.495
Time to CDA in Monozygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.79 (0.68-0.91)0.001
0.44 (0.06-3.35)0.426
 DR3 present in proband0.17 (0.02-1.46)0.106
 DR4 present in proband5.01 (0.38-65.8)0.220
CovariateHazard Ratio (95% Confidence Interval)P value
Time to IA in Dizygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.88 (0.78-1.00)0.047
 Proband’s sex0.37 (0.08-1.76)0.210
 DR3 present in proband0.95 (0.20-4.42)0.945
 DR4 present in proband0.79 (0.15-4.05)0.773
Time to IA in Monozygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.91 (0.84-0.98)0.012
 Proband’s sex0.97 (0.29-3.28)0.962
0.81 (0.26-2.51)0.716
 DR4 present in proband1.05 (0.32-3.47)0.938
Time to CDA in Dizygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.85 (0.66-1.08)0.187
 Proband’s sex0.21 (0.02-1.91)0.164
 DR3 present in proband0.43 (0.09-1.93)0.268
 DR4 present in proband0.47 (0.05-4.12)0.495
Time to CDA in Monozygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.79 (0.68-0.91)0.001
0.44 (0.06-3.35)0.426
 DR3 present in proband0.17 (0.02-1.46)0.106
 DR4 present in proband5.01 (0.38-65.8)0.220

Abbreviations: IA, islet autoimmunity; CDA, celiac autoimmunity.

Table 2.

Cox proportional hazards models for time to islet autoimmunity and celiac autoimmunity in cotwins

CovariateHazard Ratio (95% Confidence Interval)P value
Time to IA in Dizygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.88 (0.78-1.00)0.047
 Proband’s sex0.37 (0.08-1.76)0.210
 DR3 present in proband0.95 (0.20-4.42)0.945
 DR4 present in proband0.79 (0.15-4.05)0.773
Time to IA in Monozygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.91 (0.84-0.98)0.012
 Proband’s sex0.97 (0.29-3.28)0.962
0.81 (0.26-2.51)0.716
 DR4 present in proband1.05 (0.32-3.47)0.938
Time to CDA in Dizygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.85 (0.66-1.08)0.187
 Proband’s sex0.21 (0.02-1.91)0.164
 DR3 present in proband0.43 (0.09-1.93)0.268
 DR4 present in proband0.47 (0.05-4.12)0.495
Time to CDA in Monozygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.79 (0.68-0.91)0.001
0.44 (0.06-3.35)0.426
 DR3 present in proband0.17 (0.02-1.46)0.106
 DR4 present in proband5.01 (0.38-65.8)0.220
CovariateHazard Ratio (95% Confidence Interval)P value
Time to IA in Dizygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.88 (0.78-1.00)0.047
 Proband’s sex0.37 (0.08-1.76)0.210
 DR3 present in proband0.95 (0.20-4.42)0.945
 DR4 present in proband0.79 (0.15-4.05)0.773
Time to IA in Monozygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.91 (0.84-0.98)0.012
 Proband’s sex0.97 (0.29-3.28)0.962
0.81 (0.26-2.51)0.716
 DR4 present in proband1.05 (0.32-3.47)0.938
Time to CDA in Dizygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.85 (0.66-1.08)0.187
 Proband’s sex0.21 (0.02-1.91)0.164
 DR3 present in proband0.43 (0.09-1.93)0.268
 DR4 present in proband0.47 (0.05-4.12)0.495
Time to CDA in Monozygotic Cotwins
 Proband’s age at type 1 diabetes diagnosis0.79 (0.68-0.91)0.001
0.44 (0.06-3.35)0.426
 DR3 present in proband0.17 (0.02-1.46)0.106
 DR4 present in proband5.01 (0.38-65.8)0.220

Abbreviations: IA, islet autoimmunity; CDA, celiac autoimmunity.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close